Invokana: Maintaining its Gait
Invokana: Maintaining its Gait
Introduction
Invokana lawsuits have shown further movement in the court proceedings with the approval coming forth for the Plaintiff Fact Sheets along with its protocols details by the U.S. District Court, District of New Jersey. Invokana had recently made it to the news for updating the label regarding increased risk of leg and foot amputations as a new black box warning by the FDA.
Invokana had entered the market with a bang as the first SGLT2 inhibitor approved by the FDA to treat Type 2 diabetes. However, today more than 400 lawsuits are pending in the court, filed by individuals who suffered diabetic ketoacidosis, kidney damage, and other side effects due to its use.
Over the course of time, Neural IT has kept its clients happy by efficient, accurate, and timely delivery of Plaintiff Fact Sheet forms that speak of quality, with a full understanding that this step helps to streamline discovery stage by replacing formal interrogatories in large, complex litigations.
Comments
Latest News
NC to Get $150M to Boost Opioid Treatment, Recovery
Categories: Opioids
North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…
SRI Gets FDA OK for High-Dose Naloxone Trial
Categories: Opioids
SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.
The approval was granted under an Investigational New Drug (IND)…
Spokane County to Get $5M in New Opioid Settlement
Categories: Opioids
Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.
The agreement addresses the company’s role in fueling…